Bristol-Myers Squibb (BMY) Earnings Date, Estimates & Call Transcripts → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free bmy Stock Alerts $49.14 +0.21 (+0.43%) (As of 09:09 AM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateApr. 25Before Market OpensConfirmedActual EPS (Feb. 2) $1.70 Beat By $0.15 Consensus EPS (Feb. 2) $1.55 Read Call TranscriptListen to Call Get Bristol-Myers Squibb Earnings AlertsEnter your email address below to receive the latest news and earnings results for BMY and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueBMY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BMY Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry Bristol-Myers Squibb Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20244$1.51$2.07$1.72 Q2 20244$1.74$2.00$1.84 Q3 20244$1.58$1.91$1.73 Q4 20244$1.49$1.84$1.71 FY 202416$6.32$7.82$6.99 Q1 20252$1.77$1.84$1.81 Q2 20252$1.77$1.78$1.78 Q3 20252$1.69$1.74$1.72 Q4 20252$1.65$1.69$1.67 FY 20258$6.88$7.05 $6.97BMY Earnings Date and InformationBristol-Myers Squibb last released its quarterly earnings results on February 2nd, 2024. The biopharmaceutical company reported $1.70 earnings per share for the quarter, topping the consensus estimate of $1.55 by $0.15. The business had revenue of $11.48 billion for the quarter, compared to the consensus estimate of $11.19 billion. Its revenue was up .6% compared to the same quarter last year. Bristol-Myers Squibb has generated $3.86 earnings per share over the last year ($3.86 diluted earnings per share) and currently has a price-to-earnings ratio of 12.7. Earnings for Bristol-Myers Squibb are expected to grow by 6.64% in the coming year, from $6.63 to $7.07 per share. Bristol-Myers Squibb has confirmed that its next quarterly earnings report will be published on Thursday, April 25th, 2024. Bristol-Myers Squibb will be holding an earnings conference call on Thursday, April 25th at 8:00 AM Eastern. Interested parties can register for or listen to the call. or dial in at 412-317-0088 with passcode "5034750". Read More Bristol-Myers Squibb Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 4/25/2024Confirmed)------- 2/2/2024Q4 2023$1.55$1.70+$0.15$2.53$11.19 billion$11.48 billion 10/26/2023Q3 2023$1.76$2.00+$0.24$3.07$10.96 billion$10.97 billion 7/27/2023Q2 2023$1.99$1.75($0.24)$2.51$11.81 billion$11.23 billion 4/27/2023Q1 2023$1.98$2.05+$0.07$3.03$11.50 billion$11.34 billion 2/2/2023Q4 2022$1.71$1.82+$0.11$2.69$11.20 billion$11.41 billion 10/25/2022Q3 2022$1.83$1.99+$0.16$3.23$11.18 billion$11.22 billion Get the Latest News and Ratings for BMY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bristol-Myers Squibb and its competitors with MarketBeat's FREE daily newsletter. 7/27/2022Q2 2022$1.79$1.93+$0.14$3.20$11.50 billion$11.89 billion 4/29/2022Q1 2022$1.92$1.96+$0.04$3.33$11.34 billion$11.65 billion 2/4/2022Q4 2021$1.83$1.83-$2.59$12.00 billion$11.96 billion 10/26/2021Q3 2021$1.92$2.00+$0.08$3.31$11.52 billion$11.62 billion 7/27/2021Q2 2021$1.89$1.93+$0.04$3.39$11.24 billion$11.70 billion 4/28/2021Q1 2021$1.82$1.74($0.08)$2.59$11.19 billion$11.07 billion Bristol-Myers Squibb Earnings - Frequently Asked Questions When is Bristol-Myers Squibb's earnings date? Bristol-Myers Squibb has confirmed that its next quarterly earnings data will be published on Thursday, April 25th, 2024. Learn more on BMY's earnings history. Did Bristol-Myers Squibb beat their earnings estimates last quarter? In the previous quarter, Bristol-Myers Squibb (NYSE:BMY) reported $1.70 earnings per share (EPS) to beat the analysts' consensus estimate of $1.55 by $0.15. Learn more on analysts' earnings estimate vs. BMY's actual earnings. How can I listen to Bristol-Myers Squibb's earnings conference call? The conference call for Bristol-Myers Squibb's latest earnings report can be listened to online. Listen to Conference Call How can I read Bristol-Myers Squibb's conference call transcript? The conference call transcript for Bristol-Myers Squibb's latest earnings report can be read online. Read Transcript How much revenue does Bristol-Myers Squibb generate each year? Bristol-Myers Squibb (NYSE:BMY) has a recorded annual revenue of $45.01 billion. How much profit does Bristol-Myers Squibb generate each year? Bristol-Myers Squibb (NYSE:BMY) has a recorded net income of $8.03 billion. BMY has generated $3.86 earnings per share over the last four quarters. What is Bristol-Myers Squibb's price-to-earnings ratio? Bristol-Myers Squibb (NYSE:BMY) has a trailing price-to-earnings ratio of 12.73 and a forward price-to-earnings ratio of 7.41. The price/earnings-to-growth ratio is 1.48. What is Bristol-Myers Squibb's EPS forecast for next year? Bristol-Myers Squibb's earnings are expected to grow from $6.63 per share to $7.07 per share in the next year, which is a 6.64% increase. More Earnings Resources from MarketBeat Related Companies: ZTS Earnings Date PFE Earnings Date ABBV Earnings Date MRK Earnings Date JNJ Earnings Date REGN Earnings Date VRTX Earnings Date GSK Earnings Date SNY Earnings Date TAK Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Taiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later? This page (NYSE:BMY) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bristol-Myers Squibb Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
